Cyclooxygenase-2 and B-cell lymphoma-2 expression in cystitis glandularis and primary vesicle adenocarcinoma
Open Access
- 3 January 2014
- journal article
- research article
- Published by Springer Nature in BMC Urology
- Vol. 14 (1) , 2
Abstract
Background: Although cystitis glandularis (CG) is a common benign urinary bladder epithelial abnormality, it remains unclear whether CG is a premalignant lesion. Cyclooxygenase-2 (COX-2) and B-cell lymphoma-2 (Bcl-2) overexpression has recently been reported as a potential tumor initiator or promoter. We evaluated and compared COX-2 and Bcl-2 expression in CG, chronic cystitis (CC), and primary vesicle adenocarcinoma (ADC) tissues. Methods: We conducted a retrospective study to investigate COX-2 and Bcl-2 levels in CG and ADC. We obtained tissue samples from 75 patients (including 11 cases of CC, 30 typical cases of CG (CGTP), 30 cases of intestinal CG (CGIT), and 4 cases of ADC) between 1989 and 2009 from the Surgical Pathology Archives of the No. 2 People’s Hospital of Zhenjiang, affiliated with Jiangsu University. COX-2 and Bcl-2 immunohistochemical staining was performed on all tissues. Nine normal bladder epithelial specimens were evaluated as control samples. Correlations between COX-2 and Bcl-2 expression in CG were also analyzed. Results: COX-2 and Bcl-2 expression was higher in the ADC group compared to other groups (p < 0.05). COX-2 and Bcl-2 levels were higher in the CGIT group compared to the CGTP group (p = 0.000 for both). The CGIT and CGTP groups both showed higher COX-2 expression compared to the CC group (p = 0.000 for both). There was no difference in Bcl-2 expression between the CGTP and CC groups (p = 0.452). Additionally, the difference in COX-2 and Bcl-2 expression between the control and CC groups was also insignificant (p = 0.668 and p = 0.097, respectively). Finally, we found that COX-2 and Bcl-2 levels were positively related (r = 0.648, p = 0.000). Conclusion: COX-2 and Bcl-2 overexpression in the CG group suggests that CG, particularly the intestinal type, may be a premalignant lesion that converts into a tumor in the presence of carcinogens.Keywords
This publication has 30 references indexed in Scilit:
- Tumor markers of bladder cancer: the schistosomal bladder tumors versus non-schistosomal bladder tumorsJournal of Experimental & Clinical Cancer Research, 2009
- B7-H1 Expression in Wilms Tumor: Correlation With Tumor Biology and Disease RecurrenceJournal of Urology, 2008
- Expression of Cyclooxygenase-2 in Normal Urothelium, and Superficial and Advanced Transitional Cell Carcinoma of BladderJournal of Urology, 2007
- The Bcl-2 apoptotic switch in cancer development and therapyOncogene, 2007
- Inverted papilloma of the urinary bladder: a molecular genetic appraisalLaboratory Investigation, 2006
- Divergent pathway of intestinal metaplasia and cystitis glandularis of the urinary bladderLaboratory Investigation, 2006
- Cystitis glandularis in childrenBJU International, 2005
- The Role of β-Catenin Signaling in the Malignant Potential of Cystitis GlandularisJournal of Urology, 2003
- The Bcl2 family: regulators of the cellular life-or-death switchNature Reviews Cancer, 2002
- Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2Cell, 1995